Whats new
Whats new.
goetzpartners securities Research - Immutep Limited (IMM-AU): FDA fast-tracks efti as chemo alternative in NSCLC
October 9th 2022
This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.